Connaughton Bernadette insider trades
Connaughton Bernadette has filed 25 Form 4s with the SEC that we hold, for Halozyme Therapeutics, INC. (HALO) (Director), Editas Medicine, Inc. (EDIT) (Director) and SYNH (Director). Across all of them we count 0 purchases worth $0 and 13 sales worth $1.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 8 sales ($839.4K). The largest single trade was a sale of 2,977 shares of Halozyme Therapeutics, INC. worth $219.2K, dated 2025-09-02. The first filing on our record is dated 2021-10-28 and the latest 2026-10-08.
Halozyme Therapeutics, INC. (HALO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-09-02 | S, sale reported on Form 4 | 2,977 | $219.2K | 2025-09-02 |
| 2025-09-02 | S, sale reported on Form 4 | 923 | $68.4K | 2025-09-02 |
| 2025-09-02 | S, sale reported on Form 4 | 100 | $7.2K | 2025-09-02 |
| 2025-10-01 | S, sale reported on Form 4 | 500 | $37.9K | 2025-10-01 |
| 2025-10-01 | S, sale reported on Form 4 | 1,500 | $112.6K | 2025-10-01 |
| 2025-11-10 | S, sale reported on Form 4 | 2,000 | $137.0K | 2025-11-12 |
| 2025-12-01 | S, sale reported on Form 4 | 829 | $59.4K | 2025-12-01 |
| 2026-01-05 | S, sale reported on Form 4 | 2,000 | $140.5K | 2026-01-06 |
| 2026-05-01 | S, sale reported on Form 4 | 1,625 | $103.2K | 2026-05-05 |
| 2026-06-01 | S, sale reported on Form 4 | 1,625 | $107.6K | 2026-06-02 |
| 2026-07-01 | S, sale reported on Form 4 | 1,000 | $76.4K | 2026-07-02 |
| 2026-07-01 | S, sale reported on Form 4 | 625 | $48.3K | 2026-07-02 |
| 2026-08-10 | S, sale reported on Form 4 | 1,626 | $167.2K | 2026-08-11 |
Editas Medicine, Inc. (EDIT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
SYNH
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1662521) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms